EVOLVE study: The real-life clinical practice with Tezepelumab in Greece

Trial Identifier:	D5180R00032
Sponsor:	AstraZeneca
Start Date:	December 2024
Primary Completion Date:	June 2028
Study Completion Date:	June 2028
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Greece	Alexandroupoli, Greece
Greece	Athens, Greece
Greece	Corfu, Greece
Greece	Crete, Greece
Greece	Ioannina, Greece
Greece	Larisa, Greece
Greece	Patra, Greece
Greece	Thessaloniki, Greece

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.